Preeclampsia and subsequent risk of cancer in Utah

被引:37
作者
Aagaard-Tillery, Kjersti M.
Stoddard, Gregory J.
Holmgren, Calla
Lacoursiere, D. Yvette
Fraser, Alison
Mineau, Geraldine P.
Varner, Michael W.
机构
[1] Univ Utah Hlth Sci, Div Maternal Fetal Med, Dept Obstet & Gynecol, Salt Lake City, UT USA
[2] Univ Utah Hlth Sci, Div Gen Obstet & Gynecol, Dept Obstet & Gynecol, Salt Lake City, UT USA
[3] Univ Utah Hlth Sci, Div Clin Immunol, Salt Lake City, UT USA
[4] Univ Utah Hlth Sci, Sect Biostat, Salt Lake City, UT USA
[5] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA
关键词
preeclampsia; cancer;
D O I
10.1016/j.ajog.2006.06.089
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: The purpose of this study was to determine if preeclampsia is associated with a reduced risk of cancer later in life. Study design: We performed a cohort study where women with preeclampsia over the interval 1947 to 1999 were identified from the Utah Population Database. Preeclamptics (n = 17,432) were matched 1:3 with nonpreeclamptics (n = 52,296) on maternal age and birth year. Pregnancy, demographic, and cancer information was extracted from subjects and their offspring in linked datasets. Relative risk and hazard ratios were calculated. Results: In a matched analysis using univariable random-effects Poisson regression, preeclampsia was protective against the development of cancer later in life (RR 0.91, 95% CI 0.84-0.99 with P = .027). In a multivariable clustered Cox regression model with the end point of cancer later in life, preeclampsia, was associated with a lower risk of cancer (HR 0.92, 95% CI 0.85-0.99 with P = .039). These findings were supported by stratified and competing risk analyses. Conclusion: Women whose pregnancies were affected by preeclampsia have a decreased risk of developing cancer. (c) 2006 Mosby, Inc. All rights reserved.
引用
收藏
页码:691 / 699
页数:9
相关论文
共 27 条
[11]   INHIBITION OF VASCULAR ENDOTHELIAL-CELL GROWTH-FACTOR ACTIVITY BY AN ENDOGENOUSLY ENCODED SOLUBLE RECEPTOR [J].
KENDALL, RL ;
THOMAS, KA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (22) :10705-10709
[12]   A cohort study of cancer risk in relation to family histories of cancer in the Utah Population Database [J].
Kerber, RA ;
O'Brien, E .
CANCER, 2005, 103 (09) :1906-1915
[13]   Cardiovascular and thromboembolic events following hypertensive pregnancy [J].
Kestenbaum, B ;
Seliger, SL ;
Easterling, TR ;
Gillen, DL ;
Critchlow, CW ;
Stehman-Breen, CO ;
Schwartz, SM .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 42 (05) :982-989
[14]   Circulating angiogenic factors in preeclampsia [J].
Levine, RJ ;
Karumanchi, SA .
CLINICAL OBSTETRICS AND GYNECOLOGY, 2005, 48 (02) :372-386
[15]   Urinary placental growth factor and risk of preeclampsia [J].
Levine, RJ ;
Thadhani, R ;
Qian, C ;
Lam, C ;
Lim, KH ;
Yu, KF ;
Blink, AL ;
Sachs, BP ;
Epstein, FH ;
Sibai, BM ;
Sukhatme, VP ;
Karumanchi, SA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (01) :77-85
[16]   Circulating angiogenic factors and the risk of preeclampsia [J].
Levine, RJ ;
Maynard, SE ;
Qian, C ;
Lim, KH ;
England, LJ ;
Yu, KF ;
Schisterman, EF ;
Thadhani, R ;
Sachs, BP ;
Epstein, FH ;
Sibai, BM ;
Sukhatme, VP ;
Karumanchi, SA .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (07) :672-683
[17]   Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfimction, hypertension, and proteinuria in preeclampsia [J].
Maynard, SE ;
Min, JY ;
Merchan, J ;
Lim, KH ;
Li, JY ;
Mondal, S ;
Libermann, TA ;
Morgan, LP ;
Sellke, FW ;
Stillman, IE ;
Epstein, FH ;
Sukhatme, VP ;
Karumanchi, SA .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (05) :649-658
[18]   Twinning and the incidence of breast and gynecological cancers (United States) [J].
Neale, RE ;
Purdie, DM ;
Murphy, MFG ;
Mineau, GP ;
Bishop, T ;
Whiteman, DC .
CANCER CAUSES & CONTROL, 2004, 15 (08) :829-835
[19]   Pathogenesis and genetics of pre-eclampsia [J].
Roberts, JM ;
Cooper, DW .
LANCET, 2001, 357 (9249) :53-56
[20]  
Rothman K. J., 1998, MODERN EPIDEMIOLOGY